CRISPR Therapeutics, the biotech firm founded by CRISPR researcher Emmanuelle Charpentier, now at the Max Planck Institute for Infection Biology, is submitting paperwork in Europe and the US to embark on clinical trials, Wired reports.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.